News

AiCuris Starts Its First Pivotal Clinical Phase 3 Trial with Pritelivir for the Treatment of HSV Infections in Immunocompromised Subjects Based on Efficacy and Safety Data from a Phase 2 Trial

The development program focuses on the treatment of immunocompromised patients whose herpes simplex virus (HSV) infections have become resistant to...

Resonant Customers Shipped a Record 17.5 Million RF Filters in The Second Quarter of 2021 Capitalizing on WaveX™ Design Technology; Representing Year Over Year Growth of 450%

Company Exceeds Milestone of 79 Million RF Filters Shipped by Resonant’s CustomersAUSTIN, Texas, July 07, 2021 (GLOBE NEWSWIRE) -- Resonant...

error: Content is protected !!